|
C15ORF23 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.050610E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.492400E-01 |
| Normal-vs-Stage2 |
6.360600E-01 |
| Normal-vs-Stage3 |
2.219100E-03 |
| Normal-vs-Stage4 |
1.642040E-01 |
| Stage1-vs-Stage2 |
5.381000E-01 |
| Stage1-vs-Stage3 |
4.35250000000442E-05 |
| Stage1-vs-Stage4 |
3.678500E-02 |
| Stage2-vs-Stage3 |
7.280400E-02 |
| Stage2-vs-Stage4 |
3.590800E-01 |
| Stage3-vs-Stage4 |
6.391600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.680100E-02 |
| Normal-vs-AfricanAmerican |
8.716200E-01 |
| Normal-vs-Asian |
2.505800E-01 |
| Caucasian-vs-AfricanAmerican |
1.862630E-01 |
| Caucasian-vs-Asian |
3.363200E-01 |
| AfricanAmerican-vs-Asian |
1.741230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.303400E-01 |
| Normal-vs-Female |
6.020400E-03 |
| Male-vs-Female |
9.140000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.201020E-01 |
| Normal-vs-Extreme_Weight |
8.928400E-01 |
| Normal-vs-Obese |
4.913600E-02 |
| Normal-vs-Extreme_Obese |
1.048600E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.322570E-01 |
| Normal_Weight-vs-Obese |
9.001600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.756100E-02 |
| Extreme_Weight-vs-Obese |
4.536300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.715610E-01 |
| Obese-vs-Extreme_Obese |
4.124300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.403800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.606400E-02 |
| Normal-vs-Age(61-80Yrs) |
8.580000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.948400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.726780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.730200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.107700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.256200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.924200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.872600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.408600E-01 |
| Normal-VS-Type2 PRCC |
9.703800E-01 |
| Normal-VS-KIRP CIMP |
2.036800E-03 |
| Normal-VS-Unclassified PRCC |
3.886400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.117600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.457600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.462200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.043700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.590800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.23859999999299E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.616000E-01 |
| Normal-vs-N1 |
1.482920E-03 |
| Normal-vs-N2 |
3.617800E-01 |
| N0-vs-N1 |
2.882800E-03 |
| N0-vs-N2 |
2.898600E-01 |
| N1-vs-N2 |
6.933200E-01 |
|
|
